Listed

Spero Therapeutics, Inc.

SPRONasdaqCIK 1701108HealthcareFiscal year ends Dec 31

Reports and events: 174 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Spero Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2021-03-1116:31 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-077864
2021-03-1116:14 ET10-KAnnual reportPeriod 2020-12-310001564590-21-012514
2021-02-1617:29 ETSC 13D/AOwnership report, active investor, amended0001839882-21-002172
2021-02-0508:07 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-029880
2021-01-1908:01 ET8-K1.01 Entry into a material agreement0001193125-21-010857
2020-12-1708:09 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-319592
2020-12-0307:31 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-308948
2020-11-0516:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-286841
2020-11-0516:01 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-051279
2020-10-2816:06 ET8-K5.07 Shareholder vote results0001193125-20-279790
2020-09-3016:23 ETDEF 14AProxy statementPeriod 2020-10-270001193125-20-259653
2020-09-1608:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-20-246775
2020-09-1409:26 ET8-K1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-244804
2020-09-0916:48 ET8-K8.01 Other events0001193125-20-242243
2020-09-0807:43 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-240546
2020-08-0616:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-211931
2020-08-0616:02 ET10-QQuarterly reportPeriod 2020-06-300001564590-20-037710
2020-06-0409:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-160206
2020-05-1116:53 ET8-K/A5.02 Departure or appointment of officers or directors0001193125-20-139200
2020-05-0808:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-137009
2020-05-0807:51 ET10-QQuarterly reportPeriod 2020-03-310001564590-20-023243
2020-04-1608:46 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-20-108749
2020-03-1608:57 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-20-073981
2020-03-1608:23 ET10-KAnnual reportPeriod 2019-12-310001564590-20-010998
2020-02-2816:31 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-056529
2020-02-1108:30 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-030705
2020-01-3008:08 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-019086
2019-12-1917:01 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-19-319256
2019-12-0508:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-19-306821
2019-11-0416:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-19-283355
2019-11-0416:01 ET10-QQuarterly reportPeriod 2019-09-300001564590-19-039770
2019-10-0312:19 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-19-261358
2019-09-0608:45 ET8-K5.02 Departure or appointment of officers or directors0001193125-19-239450
2019-08-0816:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-19-216834
2019-08-0816:01 ET10-QQuarterly reportPeriod 2019-06-300001564590-19-030746
2019-06-1308:13 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-19-171876
2019-06-0616:40 ET8-K5.07 Shareholder vote results0001193125-19-167255
2019-05-0916:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-19-142982
2019-05-0916:01 ET10-QQuarterly reportPeriod 2019-03-310001564590-19-017941
2019-04-2616:22 ETDEF 14AProxy statementPeriod 2019-06-050001193125-19-122422
2019-04-1817:03 ET8-K5.02 Departure or appointment of officers or directors0001193125-19-111025
2019-03-2916:54 ET8-K/A5.02 Departure or appointment of officers or directors0001193125-19-092830
2019-03-1908:11 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-19-078993
2019-03-1416:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-19-074792
2019-03-1416:04 ET10-KAnnual reportPeriod 2018-12-310001564590-19-007805
2019-01-0717:01 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-003882
2018-11-1609:01 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-18-328530
2018-11-1308:46 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-324949
2018-11-0816:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-322565
2018-11-0816:02 ET10-QQuarterly reportPeriod 2018-09-300001564590-18-028526

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.